Vascular Access Devices Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030

The vascular access devices market size was valued at US$ 6.2 billion in 2020 and is projected to expand at a CAGR of 6.1% from 2021 to 2030. The vascular access devices market size is expected to reach over US$ 10.5 billion by 2030.

Increase in number of lifestyle diseases, Increase in incidences of target diseases, and technological innovations are projected to drive the global vascular access devices market during the forecast period.

Key Drivers

  • Unhealthy lifestyle and diet, lack of exercise are some of the factors responsible for increasing incidences of lifestyle diseases such as diabetes, blood pressure and obesity.
  • According to International Diabetes Federation (IDF), in 2014, around 338 Mn people were diagnosed with diabetes, and according to WHO, in 2014, around 1.9 Bn adult population, was obese or overweight.
  • Thus, increasing incidences of lifestyle diseases propels the need for hospitalization, thereby, driving the demand for vascular access devices market.

Increase in Incidences of Target diseases to Boost Market Growth

  • Cancer is one of the leading cause for rising demand of vascular access devices globally. In 2014, U.S. alone had an estimated 1.6 million new cancer cases.
  • According to WHO, in 2013, there were an estimated 14.8 Mn. new cancer cases worldwide.
  • Rising number of cancer cases increases the demand for central venous catheters, and new totally implantable ports, for administration of chemotherapy medications.

Technological Innovations to Drive Market

  • Innovative technologies, products and procedures are constantly fueling the growth in the market. New catheter material compositions that improve user’s pre and post-catheterization comfort, antimicrobial coatings that prevent the formation of biofilms and crusts are some of the advances, which manufacturers and researchers are developing.
  • Biocompatible materials, such as silicone and polymer mixes, are substituting latex materials, giving rise to lubricious internal and external surfaces that reduce pain during Administrations. Silicon coated and 100% silicone catheters are already in widespread use in cases where patients are allergic or hypersensitive to latex.
  • Antimicrobial coating, and drug coated catheters are the most recently approved products by the U.S.-FDA, that have reduced catheter related infections, and complications.

Peripheral Catheters Segment to Dominate Market

  • In terms of product, the vascular access devices market is segmented into peripheral catheters, central catheters, and accessories. Peripheral catheters segment is segmented into PIVC and midline catheters. The central catheters are further classified into PICC, Central Venous Catheters, Implantable ports, and dialysis catheters.
  • Peripheral catheters accounted to larger market share in terms of revenue in 2018 and expected to grow in the forecast period due to due to cost effectiveness, ease of insertion, reduced complication risks associated with use of other catheters, and government regulations.
  • Peripheral catheters are most widely accepted catheters globally, especially in emerging economies, due to advantages over central catheters such as ease of administration, less frequency of catheter related complications, lesser duration of usage (around one week), and cost effectiveness. Hence, the segment holds higher share globally in vascular access devices market.

Medication Administration segment to be Highly Lucrative Segment

  • By application, the vascular access devices market is segmented into medication administration, administration of fluids and nutritional compounds, transfusion of blood products, and diagnostic testing.
  • Medication administration segment accounted for larger market share in terms of revenue in 2020, medication administration segmented accounted for more than 45% of the market share in 2018 due to high prevalence and rise in incidence rates of chronic disorders across the globe.

Intravenous Route segment to dominate the Market

  • By route of administration, the vascular access devices market is segmented into intravenous route and subcutaneous route.
  • Intravenous route segment accounted for larger market share in terms of revenue in 2020, intravenous route segmented accounted for more than 75% of the market share in 2020 due to reliability and rapid delivery of medication. Increasing use of PICC and PIVC devices support the growth of the intravenous Route of Administration segment.

Hospitals Segment to offer attractive opportunity

  • Based on the end-user, the market has been segmented into hospitals, clinics, ambulatory surgical centers and diagnostic centers.
  • The hospitals segment dominated the market in 2020 and is anticipated to remain dominant in the forecast period owing to the increasing demand for minimal invasive procedures and increasing number of surgeries for vascular diseases. 

North America to Dominate Global Market

  • In terms of region, the global vascular access devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • North America dominated the global vascular access devices in 2020 and is estimated to maintain its leading position by the end of 2027 with sight decline in the market share.
  • Increased adoption of technological advanced products in the region, high prevalence of vascular disorders, rapidly aging population, and well established healthcare infrastructure etc. factors have contributed to dominant share of the region in global market.  
  • The market in the Asia Pacific region is projected to expand at exponential growth rate during the forecast period. The highest growth rate in the Asia Pacific region is attributed to increased market penetration of global players in highly populous countries such as China, India, Taiwan, rapidly improving healthcare industry in the region, and comparatively large patient pool with vascular and chronic disorders.

Competitive Landscape

  • The global vascular access devices market is fragmented in terms of number of players. Key players operating in the global vascular access devices market includes, include B. Braun Melsungen AG, Baxter International, Becton, Dickinson and Company, Cook Medical, Medtronic plc, W. L. Gore & Associates, Inc., Teleflex, Inc., Siemens Healthineers, Nipro Medical Corporation and Fresenius Medical Care.

Market Segmentation:

By Product

  • Peripheral Catheters
    • PIVC
    • Midline Catheters
  • Central Catheters
    • PICC
    • Central Venous Catheters
    • Dialysis Catheters
    • Implantable Ports
  • Accessories

By Application

  • Medication Administration
  • Administration of Fluid and Nutrition
  • Transfusion of Blood Products
  • Diagnostic Testing

By Route of Administration

  • Subcutaneous
  • Intravenous

By End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Laboratories

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific          
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

Table of Contents

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Vascular Access Devices Market

4. Market Overview

    4.1. Introduction

    4.2. Key Industry Developments

5. Market Dynamics

    5.1. Drivers

    5.2. Restraints

    5.3. Opportunities

    5.4. Trends

    5.5. Global Vascular Access Devices Market Size (US$ Mn) Forecast, 2017–2030

    5.6. Global Vascular Access Devices Market Volume (Units) Forecast, 2017–2030

    5.7. Global Vascular Access Devices Market Outlook

    5.8. Porters Analysis

    5.9. Value Chain Analysis

6. Global Vascular Access Devices Market Analysis and Forecast, by Product

    6.1. Key Findings

    6.2. Introduction

    6.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2030

        6.3.1. Peripheral Catheters

            6.3.1.1. PIVC

            6.3.1.2. Midline Catheters

        6.3.2. Central Catheters

            6.3.2.1. PICC

            6.3.2.2. Central Venous Catheters

            6.3.2.3. Dialysis Catheters

            6.3.2.4. Implantable Ports

        6.3.3. Accessories

    6.4. Market Attractiveness Analysis, by Product

    6.5. Key Trends

7. Global Vascular Access Devices Market Analysis and Forecasts, by Application

    7.1. Key Findings

    7.2. Introduction

    7.3. Market size (US$ Mn) Forecast, by Application, 2019-2030

        7.3.1. Medication Administration

        7.3.2. Administration of Fluid and Nutrition

        7.3.3. Transfusion of Blood Products

        7.3.4. Diagnostic Testing

    7.4. Market Attractiveness Analysis, by Application

8. Global Vascular Access Devices Market Analysis and Forecasts, by Route of Administration

    8.1. Key Findings

    8.2. Introduction

    8.3. Market size (US$ Mn) Forecast, by Route of Administration, 2019-2030

        8.3.1. Subcutaneous

        8.3.2. Intravenous

    Market Attractiveness Analysis, by Route of Administration

9. Global Vascular Access Devices Market Analysis and Forecasts, by End-user

    9.1. Key Findings

    9.2. Introduction

    9.3. Market size (US$ Mn) Forecast by End-user, 2019-2030

        9.3.1. Hospitals

        9.3.2. Clinics

        9.3.3. Ambulatory Surgery Centers

        9.3.4. Diagnostic Laboratories

    9.4. Market Attractiveness Analysis, by End-user

10. Global Vascular Access Devices market Analysis and Forecasts, by Region

    10.1. Key Findings

    10.2. Global Market Scenario

    10.3. Market Value (US$ Mn) Forecast, by Region, 2019-2030

        10.3.1. North America

        10.3.2. Europe

        10.3.3. Asia Pacific

        10.3.4. Latin America

        10.3.5. Middle East & Africa

    10.4. Market Attractiveness Analysis, by Region

    10.5. Key Trends, By Region

11. North America Vascular Access Devices market Analysis and Forecast

    11.1. Key Findings

    11.2. Market Value (US$ Mn) Forecast, by Country, 2019-2030

        11.2.1. U.S.

        11.2.2. Canada

    11.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2030

        11.3.1. Peripheral Catheters

            11.3.1.1. PIVC

            11.3.1.2. Midline Catheters

        11.3.2. Central Catheters

            11.3.2.1. PICC

            11.3.2.2. Central Venous Catheters

            11.3.2.3. Dialysis Catheters

            11.3.2.4. Implantable Ports

        11.3.3. Accessories

    11.4. Market size (US$ Mn) Forecast, by Application, 2019-2030

        11.4.1. Medication Administration

        11.4.2. Administration of Fluid and Nutrition

        11.4.3. Transfusion of Blood Products

        11.4.4. Diagnostic Testing

    11.5. Market size (US$ Mn) Forecast, by Route of Administration, 2019-2030

        11.5.1. Subcutaneous

        11.5.2. Intravenous

    11.6. Market size (US$ Mn) Forecast by End-user, 2019-2030

        11.6.1. Hospitals

        11.6.2. Clinics

        11.6.3. Ambulatory Surgery Centers

        11.6.4. Diagnostic Laboratories

    11.7. Market Attractiveness Analysis

        11.7.1. By Country

        11.7.2.  By Product

        11.7.3. By Application

        11.7.4. By Route of Administration

        11.7.5. By End-user

12. Europe Vascular Access Devices market Analysis and Forecast

    12.1. Key Findings

    12.2. Market Value (US$ Mn) Forecast By Country/Sub-region, 2019-2030

        12.2.1. Germany

        12.2.2. U.K.

        12.2.3. France

        12.2.4. Italy

        12.2.5. Spain

        12.2.6. Rest of Europe

    12.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2030

        12.3.1. Peripheral Catheters

            12.3.1.1. PIVC

            12.3.1.2. Midline Catheters

        12.3.2. Central Catheters

            12.3.2.1. PICC

            12.3.2.2. Central Venous Catheters

            12.3.2.3. Dialysis Catheters

            12.3.2.4. Implantable Ports

        12.3.3. Accessories

    12.4. Market Value (US$ Mn) Forecast, by Application, 2019-2030

        12.4.1. Medication Administration

        12.4.2. Administration of Fluid and Nutrition

        12.4.3. Transfusion of Blood Products

        12.4.4. Diagnostic Testing

    12.5. Market Value (US$ Mn) Forecast, by Route of Administration, 2019-2030

        12.5.1. Subcutaneous

        12.5.2. Intravenous

    12.6. Market Value (US$ Mn) Forecast by End-user, 2019-2030

        12.6.1. Hospitals

        12.6.2. Clinics

        12.6.3. Ambulatory Surgery Centers

        12.6.4. Diagnostic Laboratories

    12.7. Market Attractiveness Analysis

        12.7.1. By Country/Sub-region

        12.7.2.  By Product

        12.7.3. By Application

        12.7.4. By Route of Administration

        12.7.5. By End-user

13. Asia Pacific Vascular Access Devices market Analysis and Forecast

    13.1. Key Findings / Developments

    13.2. Market Overview

    13.3. Market size (US$ Mn) Forecast, by Country/Sub-region, 2019-2030

        13.3.1. China

        13.3.2. India

        13.3.3. Japan

        13.3.4. Australia & New Zealand

        13.3.5. Rest of Asia Pacific

    13.4. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2030

        13.4.1. Peripheral Catheters

            13.4.1.1. PIVC

            13.4.1.2. Midline Catheters

        13.4.2. Central Catheters

            13.4.2.1. PICC

            13.4.2.2. Central Venous Catheters

            13.4.2.3. Dialysis Catheters

            13.4.2.4. Implantable Ports

        13.4.3. Accessories

    13.5. Market Value (US$ Mn) Forecast, by Application, 2019-2030

        13.5.1. Medication Administration

        13.5.2. Administration of Fluid and Nutrition

        13.5.3. Transfusion of Blood Products

        13.5.4. Diagnostic Testing

    13.6. Market Value (US$ Mn) Forecast, by Route of Administration, 2019-2030

        13.6.1. Subcutaneous

        13.6.2. Intravenous

    13.7. Market Value (US$ Mn) Forecast by End-user, 2019-2030

        13.7.1. Hospitals

        13.7.2. Clinics

        13.7.3. Ambulatory Surgery Centers

        13.7.4. Diagnostic Laboratories

    13.8. Market Attractiveness Analysis

        13.8.1. By Country/Sub-region

        13.8.2.  By Product

        13.8.3. By Application

        13.8.4. By Route of Administration

        13.8.5. By End-user

14. Latin America Vascular Access Devices market Analysis and Forecast

    14.1. Key Findings / Developments

    14.2. Market Overview

    14.3. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019-2030

        14.3.1. Brazil

        14.3.2. Mexico

        14.3.3. Rest of Latin America

    14.4. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2030

        14.4.1. Peripheral Catheters

            14.4.1.1. PIVC

            14.4.1.2. Midline Catheters

        14.4.2. Central Catheters

            14.4.2.1. PICC

            14.4.2.2. Central Venous Catheters

            14.4.2.3. Dialysis Catheters

            14.4.2.4. Implantable Ports

        14.4.3. Accessories

    14.5. Market Value (US$ Mn) Forecast, by Application, 2019-2030

        14.5.1. Medication Administration

        14.5.2. Administration of Fluid and Nutrition

        14.5.3. Transfusion of Blood Products

        14.5.4. Diagnostic Testing

    14.6. Market Value (US$ Mn) Forecast, by Route of Administration, 2019-2030

        14.6.1. Subcutaneous

        14.6.2. Intravenous

    14.7. Market Value (US$ Mn) Forecast by End-user, 2019-2030

        14.7.1. Hospitals

        14.7.2. Clinics

        14.7.3. Ambulatory Surgery Centers

        14.7.4. Diagnostic Laboratories

    14.8. Market Attractiveness Analysis

        14.8.1. By Country/Sub-region

        14.8.2.  By Product

        14.8.3. By Application

        14.8.4. By Route of Administration

        14.8.5. By End-user

15. Middle East and Africa Vascular Access Devices market Analysis and Forecast

    15.1. Key Findings / Developments

    15.2. Market Overview

    15.3. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019-2030

        15.3.1. GCC Countries

        15.3.2. South Africa

        15.3.3. Rest of Middle East and Africa

    15.4. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019-2030

        15.4.1. Peripheral Catheters

            15.4.1.1. PIVC

            15.4.1.2. Midline Catheters

        15.4.2. Central Catheters

            15.4.2.1. PICC

            15.4.2.2. Central Venous Catheters

            15.4.2.3. Dialysis Catheters

            15.4.2.4. Implantable Ports

        15.4.3. Accessories

    15.5. Market Value (US$ Mn) Forecast, by Application, 2019-2030

        15.5.1. Medication Administration

        15.5.2. Administration of Fluid and Nutrition

        15.5.3. Transfusion of Blood Products

        15.5.4. Diagnostic Testing

    15.6. Market Value (US$ Mn) Forecast, by Route of Administration, 2019-2030

        15.6.1. Subcutaneous

        15.6.2. Intravenous

    15.7. Market Value (US$ Mn) Forecast by End-user, 2019-2030

        15.7.1. Hospitals

        15.7.2. Clinics

        15.7.3. Ambulatory Surgery Centers

        15.7.4. Diagnostic Laboratories

    15.8. Market Attractiveness Analysis

        15.8.1. By Country/Sub-region

        15.8.2.  By Product

        15.8.3. By Application

        15.8.4. By Route of Administration

        15.8.5. By End-user

16. Competition Landscape

    16.1. Global Vascular Access Devices Market Share, by Company, 2018

    16.2. Market Player – Competition Matrix (By Tier and Size of companies)

    16.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        16.3.1. B. Braun Melsungen AG

            16.3.1.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2.Product Portfolio

            16.3.1.3.SWOT Analysis

            16.3.1.4.Strategic Overview

        16.3.2. Baxter International.  

            16.3.2.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2.Product Portfolio

            16.3.2.3.SWOT Analysis

            16.3.2.4.Strategic Overview

        16.3.3. Becton, Dickinson and Company

            16.3.3.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2.Product Portfolio

            16.3.3.3.SWOT Analysis

            16.3.3.4.Financial Overview

            16.3.3.5.Strategic Overview

        16.3.4. C. R. Bard.

            16.3.4.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2.Product Portfolio

            16.3.4.3.SWOT Analysis

            16.3.4.4.Financial Overview

            16.3.4.5.Strategic Overview

        16.3.5. Cook Medical

            16.3.5.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2.Product Portfolio

            16.3.5.3.SWOT Analysis

            16.3.5.4.Financial Overview

            16.3.5.5.Strategic Overview

        16.3.6. Medtronic plc.

            16.3.6.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2.Product Portfolio

            16.3.6.3.SWOT Analysis

            16.3.6.4.Financial Overview

            16.3.6.5.Strategic Overview

        16.3.7. Siemens Healthineers

            16.3.7.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2.Product Portfolio

            16.3.7.3.SWOT Analysis

            16.3.7.4.Financial Overview

            16.3.7.5.Strategic Overview

        16.3.8. Teleflex, Inc.

            16.3.8.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2.Product Portfolio

            16.3.8.3.SWOT Analysis

            16.3.8.4.Financial Overview

            16.3.8.5.Strategic Overview

        16.3.9. Nipro Medical Corporation

            16.3.9.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2.Product Portfolio

            16.3.9.3.SWOT Analysis

            16.3.9.4.Financial Overview

            16.3.9.5.Strategic Overview

        16.3.10. Fresenius Medical Care

            16.3.10.1.Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2.Product Portfolio

            16.3.10.3.SWOT Analysis

            16.3.10.4.Financial Overview

            16.3.10.5.Strategic Overview

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert